| |
| Saturday, November 10, 2007 |
Welcome and Introductions Anne Louise Coleman, MD PhD - 8:00 AM (0h 0m 39s) -  - View |
American Glaucoma Society Introduction Robert N Weinreb, MD - 8:02 AM (0h 0m 52s) -  - View |
| Point-Counterpoint: Should Multifocal Lenses Be Used in Glaucoma Patients With Moderate Visual Field Loss? |
Introduction George L Spaeth, MD FACS - 4:46 PM (0h 0m 18s) -  - View |
Yes Alan S Crandall, MD - 4:47 PM (0h 5m 41s) -   - View |
No Thomas W Samuelson, MD - 4:52 PM (0h 5m 9s) -   - View |
Rebuttal Alan S Crandall, MD - 4:57 PM (0h 2m 48s) -  - View |
Rebuttal Thomas W Samuelson, MD - 5:02 PM (0h 3m 6s) -   - View |
Conclusion George L Spaeth, MD FACS - 5:07 PM (0h 2m 1s) -  - View |
Closing Remarks Anne Louise Coleman, MD PhD - 5:09 PM (0h 0m 7s) -  - View |
| Point-Counterpoint: Which Is More Important? |
Absolute IOP Level Claude F Burgoyne, MD - 8:37 AM (0h 6m 48s) -   - View |
IOP Fluctuation Joseph Caprioli, MD FACS - 8:44 AM (0h 6m 54s) -   - View |
Rebuttal Claude F Burgoyne, MD - 8:51 AM (0h 1m 50s) -   - View |
Rebuttal Joseph Caprioli, MD FACS - 8:53 AM (0h 1m 53s) -   - View |
Conclusion Janet B Serle, MD - 8:55 AM (0h 2m 19s) -  - View |
| Section I: Finding the "Perfect" IOP |
Introduction Janet B Serle, MD - 8:07 AM (0h 1m 1s) -  - View |
Best Instruments for Measuring IOP Leon W Herndon, MD - 8:08 AM (0h 6m 50s) -   - View |
Biomechanical Properties of the Cornea David F Garway-Heath, MD FRCOphth - 8:15 AM (0h 7m 23s) -   - View |
Role of Central Corneal Thickness in Interpreting IOP Level James D Brandt, MD - 8:22 AM (0h 7m 10s) -   - View |
Systemic and Circadian Influences on IOP Sanjay G Asrani, MD - 8:29 AM (0h 7m 4s) -   - View |
| Section II: Finding the "Perfect" Eye Drop |
Introduction Theodore Krupin, MD - 8:57 AM (0h 2m 25s) -   - View |
Case Presentation of an Eye With Corneal Toxicity From Topical Glaucomatous Medications Jason Bacharach, MD - 8:58 AM (0h 3m 18s) -   - View |
Case Discussion: What Is the Differential Diagnosis? What Tests Will Help Make a Diagnosis? Douglas J Rhee, MD - 9:02 AM (0h 2m 54s) -   - View |
Case Discussion: Management of Patient With Medications Fotis Topouzis, MD - 9:06 AM (0h 4m 9s) -   - View |
Case Discussion: Management of Patient With Other Therapeutic Interventions Ronald L Gross, MD - 9:10 AM (0h 4m 23s) -   - View |
Discussion Wrap-Up Theodore Krupin, MD - 9:14 AM (0h 0m 33s) -  - View |
Systemic Complications From Topical Glaucoma Medications Allan J Flach, MD - 9:16 AM (0h 5m 52s) -   - View |
Use of Prostaglandin Analogues in an Inflamed Eye Simon K Law, MD - 9:21 AM (0h 4m 18s) -   - View |
Tips for Improving Patient Adherence/Compliance Paul P Lee, MD JD - 9:26 AM (0h 5m 13s) -   - View |
Conclusion Theodore Krupin, MD - 9:31 AM (0h 0m 34s) -  - View |
| Section III: Keeping Your Eye on the Future |
Introduction Robert N Weinreb, MD - 9:33 AM (0h 0m 28s) -  - View |
Update on Neuroprotection Jeffrey M Liebmann, MD - 9:35 AM (0h 7m 51s) -   - View |
Update on New Pharmaceutical Products Gary D Novack, PhD - 9:42 AM (0h 7m 29s) -   - View |
Update on New Methods of Diagnosing Glaucoma Felipe A Medeiros, MD - 9:49 AM (0h 7m 13s) -   - View |
Current Thoughts About the Pathophysiology of Glaucoma George A Cioffi, MD - 9:56 AM (0h 8m 42s) -   - View |
Conclusion Robert N Weinreb, MD - 10:03 AM (0h 1m 30s) -  - View |
| Section IV: Making Sense of Multicenter Clinical Trials |
Introduction Harry A Quigley, MD - 10:40 AM (0h 0m 48s) -  - View |
Update and Clinical Pearls From the Advanced Glaucoma Intervention Study (AGIS) Douglas E Gaasterland, MD - 10:41 AM (0h 6m 30s) -   - View |
Update and Clinical Pearls From the Collaborative Initial Glaucoma Treatment Study (CIGTS) Richard P Mills, MD MPH - 10:48 AM (0h 6m 37s) -   - View |
Update and Clinical Pearls From the Ocular Hypertension Treatment Study (OHTS) Michael A Kass, MD - 10:55 AM (0h 5m 24s) -   - View |
Update and Clinical Pearls From the European Glaucoma Prevention Study (EGPS) Stefano Miglior, MD - 11:02 AM (0h 7m 19s) -   - View |
Update and Clinical Pearls From the Early Manifest Glaucoma Trial (EMGT) Anders H Heijl, MD, PhD - 11:09 AM (0h 7m 8s) -   - View |
Update and Clinical Pearls From the Tube vs. Trabeculectomy Study (TVT) Steven Gedde, MD - 11:16 AM (0h 6m 52s) -   - View |
Conclusion Harry A Quigley, MD - 11:23 AM (0h 3m 45s) -  - View |
| Section IX: Management of Angle-Closure Glaucoma: Not as Simple as It Used to Be |
Introduction Ivan Goldberg, MBBS FRANZCO - 4:11 PM (0h 2m 28s) -   - View |
Case Presentation of an Eye With Acute Angle-Closure Attack and Cloudy Cornea Teresa C Chen, MD - 4:12 PM (0h 2m 58s) -   - View |
Case Discussion: Patient Should First Be Managed With IOP-Lowering Medications, Then Iridotomy Shan C Lin, MD - 4:16 PM (0h 4m 38s) -   - View |
Case Discussion: Patient Should First Be Managed With Iridoplasty, Then Iridotomy Paul R Healey, MD - 4:20 PM (0h 3m 58s) -   - View |
Discussion Wrap-Up Ivan Goldberg, MBBS FRANZCO - 4:24 PM (0h 1m 11s) -   - View |
Role of Cataract Surgery in Angle-Closure Glaucoma David S Friedman, MD MPH PhD - 4:26 PM (0h 6m 0s) -   - View |
Role of Ultrasound Biomicroscopy in Angle-Closure Glaucoma Joel S Schuman, MD - 4:31 PM (0h 6m 11s) -   - View |
Conclusion Ivan Goldberg, MBBS FRANZCO - 4:36 PM (0h 2m 18s) -   - View |
| Section V: The Bread and Butter of Glaucoma: Ocular Hypertension and the Diagnosis of Glaucoma |
Case Presentation of a Glaucoma Suspect Patient With Ocular Hypertension Annette L Giangiacomo, MD - 1:16 PM (0h 2m 57s) -   - View |
Case Discussion: Assessing the Risk that This Patient Will Develop Glaucoma Robert L Stamper, MD - 1:20 PM (0h 4m 39s) -   - View |
Case Discussion: At What Level of Risk Would You Treat This Patient? Richard Parrish, II MD - 1:24 PM (0h 4m 21s) -   - View |
Case Discussion: If You Decide to Treat, What Do You Use? Jody R Piltz-Seymour, MD - 1:28 PM (0h 4m 35s) -   - View |
Update on Diagnosis of Glaucoma With Visual Field Testing Pamela A Sample, PhD - 1:35 PM (0h 6m 42s) -   - View |
Update on Diagnosis of Glaucoma With Optic Nerve Imaging David S Greenfield, MD - 1:42 PM (0h 7m 19s) -   - View |
Conclusion Dale K Heuer, MD - 1:49 PM (0h 3m 46s) -   - View |
| Section VI: The Challenge: Dealing With Progressive Glaucomatous Optic Nerve Damage |
Introduction Louis R Pasquale, MD - 1:51 PM (0h 0m 43s) -  - View |
Glaucoma Progression Can Be Stopped With IOP Reduction Paul F Palmberg, MD PhD - 1:52 PM (0h 7m 46s) -   - View |
Glaucoma Progression Can Not Be Stopped With IOP Reduction Kuldev Singh, MD MPH - 1:59 PM (0h 6m 59s) -   - View |
Rebuttal Paul F Palmberg, MD PhD - 2:06 PM (0h 2m 14s) -   - View |
Rebuttal Kuldev Singh, MD MPH - 2:08 PM (0h 1m 47s) -   - View |
Detecting Progression With Optic Nerve Imaging Balwantray C Chauhan, PhD - 2:10 PM (0h 7m 28s) -   - View |
Detecting Progression With Visual Field Testing Christopher A Girkin, MD - 2:17 PM (0h 6m 53s) -   - View |
Conclusion Louis R Pasquale, MD - 2:24 PM (0h 1m 17s) -  - View |
| Section VII: Improving Your Glaucoma Surgery Outcomes |
Trabeculectomy: Avoiding Complications Garry P Condon, MD - 2:27 PM (0h 5m 28s) -   - View |
Remodeling a Filtering Bleb Andrew George Iwach, MD - 2:32 PM (0h 5m 43s) -   - View |
Repair of a Leaking Filtering Bleb Herbert P Fechter, MD - 2:37 PM (0h 5m 10s) -   - View |
Nonpenetrating Procedures: Avoiding Complications Thierry G Zeyen, MD, PhD - 2:42 PM (0h 5m 35s) -   - View |
Ex-PRESS Miniature Glaucoma Device: Avoiding Complications Peter Andreas Netland, MD PhD - 2:47 PM (0h 4m 45s) -   - View |
Drainage Device Surgery: Avoiding Complications Donald L Budenz, MD, MPH - 2:52 PM (0h 5m 51s) -   - View |
Conclusion Donald S Minckler, MD - 2:57 PM (0h 0m 36s) -  - View |
| Section VIII: Risk Factors? Prognostic Factors? |
Introduction Ravi Thomas, MBBS - 3:40 PM (0h 1m 15s) -   - View |
Gender Eve J Higginbotham, MD - 3:41 PM (0h 7m 11s) -   - View |
Sleep Apnea Christopher A Girkin, MD - 3:48 PM (0h 5m 44s) -   - View |
Perfusion Pressure M. Cristina Leske, MD MPH - 3:55 PM (0h 7m 28s) -   - View |
Disk Hemorrhages Rohit Varma, MD MPH - 4:02 PM (0h 7m 32s) -   - View |
Conclusion Ravi Thomas, MBBS - 4:09 PM (0h 2m 5s) -   - View |
| Section X: Improving Visual Functioning of the Glaucoma Patient |
Introduction George L Spaeth, MD FACS - 4:38 PM (0h 1m 9s) -  - View |
Restoring Visual Functioning Through Rehabilitation Eydie G Miller, MD - 4:39 PM (0h 8m 28s) -   - View |
| The American Glaucoma Society (AGS) Subspecialty Day Lecture |
Presentation of the Lecturer Robert N Weinreb, MD - 11:27 AM (0h 6m 31s) -   - View |
Risk Factor: The Concept, the Evolution, and the Practice M Roy Wilson, MD - 11:32 AM (0h 18m 4s) -   - View |